We are excited to announce the release of our updated "Author Guidelines" for Cardiac and Cardiovascular Research.

One of the most noticeable changes is that for research articles with more than one author, the statement of "Author contributions" is required. As of Volume 5 in 2024, papers will be published in this new style.

For any questions, please contact the editorial office at editorial-ccr@apacsci.com.

The latest 2023 issue of Cardiac and Cardiovascular Research, Volume 4, Issue 1, is now live.

Click the DOI link to view the full issue: https://doi.org/10.54517/ccr.v4i1

The Editorial Office of Cardiac and Cardiovascular Research

The researchers demonstrate that cardiac fibroblasts function as antigen-presenting cells and contribute to cardiac fibrosis and dysfunction through MHCII induced by IFN-γ.

Cardiac and Cardiovascular Research (CCR) is a new peer reviewed journal, and it is published by: Asia Pacific Academy of Science Pte. Ltd.

Cardiac and Cardiovascular Research (CCR) receives financial support from Beijing Chuncheng Education Publications Research Center, hence the APC is free for authors for the time being. The editorial office of CCR expresses its sincere thanks to the sponsor. 

More information, please visit the website: https://aber.apacsci.com/index.php/ccr/index  

E-mail: editorial-ccr@apacsci.com

Editorial Office of Cardiac and Cardiovascular Research (CCR)